ASX Announcements
Clinuvel Pharmaceuticals (ASX: CUV) – Decade of profitability fuels U.S. expansion
Clinuvel Pharmaceuticals has delivered its tenth consecutive annual profit, capping off a decade of commercial operations that has generated a 31%...
Clinuvel Pharmaceuticals (ASX: CUV) – Files 2026 Annual Report and Appendix 4E
Clinuvel Pharmaceuticals reported a year ending 30 June 2026 with revenues declining 1 percent to A$94.0 million and net profit falling 6 percent to...
State Street SPDR S&P/ASX 200 ETF (ASX: STW) – STW Files 2025 Annual Report
State Street Global Advisors has released the annual reports for three SPDR Core Equity ETFs for the financial year ended 30 June 2026, with each...
Objective Corporation (ASX: OCL) – Objective Files FY2026 Investor Presentation
Objective Corporation has delivered solid full-year results for FY2026, with revenue rising 9 percent to $135 million and adjusted EBITDA climbing...
Centuria Capital (ASX: CNI) – Chief Executive Officer Transition Announced
Centuria Capital Group has announced a planned leadership transition, with Jason Huljich set to assume the role of sole Group Chief Executive...
Objective Corporation (ASX: OCL) – CEO Letter to Shareholders Seven
Objective Corporation disclosed two material headwinds heading into FY2027, even as its software business maintains solid underlying growth. An...
Objective Corporation (ASX: OCL) – Objective FY2026 Full Year Results
Objective Corporation has delivered solid financial growth in FY2026, with revenue advancing 9% to $134.7 million and adjusted EBITDA increasing 11%...
Objective Corporation (ASX: OCL) – Objective Files Preliminary Final Report
Objective Corporation delivered mixed results in its financial year 2026, with revenue climbing 9 percent to $134.7 million and adjusted EBITDA...
Cromwell Property Group (ASX: CMW) – CMW Files FY26 Results Presentation
Cromwell Property Group's FY26 results reveal a company successfully executing its growth strategy, with funds from operations climbing 5 percent to...
Omni Bridgeway (ASX: OBL) – FY26 Full Year Results Investor Presentation
Omni Bridgeway has reported record cash investment proceeds for the 12 months to 30 June 2026, reaching A$350.5 million, up 49 percent on the prior...